ELF
European Lead Factory
Site Search
Site Search
Displaying results 811 - 820 of 893
20th Edition - December 2012
Table of contents:
- IMI 8th Call launched
- New IMI projects get underway
- Commission president cites IMI in speech to European Parliament
- Save the date! Joint IMI – C-Path event in Brussels on 7 March
- InnovaHealth report highlights need for new healthcare PPP
- IMI projects having impact on R&D productivity, new paper shows
- IMI in the news
- IMI presentations at forthcoming conferences
- Season’s Greetings
- News from the projects
19th Edition - November 2012
Table of contents:
- IMI’s 8th Call scheduled for launch in December
- Top tips for finding project partners
- IMI European Parliament event highlights benefits of PPPs
- Independent Observers positive on 5th Call Stage 2 evaluation
- New IMI brochure released
- Financial workshops help project participants with rules
- CDISC workshop puts standards in the spotlight
- IMI on air
- IMI presentations at forthcoming conferences
- News from the projects
18th Edition – October 2012
Table of contents:
- Health Research at a Crossroads – Are Public-Private Partnerships the Way Forward?
- IMI in the spotlight in Cyprus
- IMI 8th Call for proposals – outlines of all indicative topics now online
- Independent observers: 6th Call Stage 1 evaluations conducted professionally and fairly
- IMI presentations at forthcoming conferences
- News from the projects
Health Research at a Crossroads
High-level experts from the European Commission and the pharmaceutical industry, as well as representatives of IMI projects and stakeholder groups, discussed the future of health research in Europe in front of a packed room at the European Parliament in Brussels on Tuesday 13 ...
Connecting new science, research and healthcare needs
The workshop jointly organised by IMI and the European Federation of Pharmaceutical Industries and Associations ( EFPIA ) at the European Health Forum in Bad Hofgastein, Austria on 4 October was the scene of a lively debate on innovation and the pharmaceutical business model. The ...
STEMBANCC
Stem cells for biological assays of novel drugs and predictive toxicology
ORBITO
Oral biopharmaceutics tools
K4DD
Kinetics for Drug Discovery
eTRIKS
Delivering European Translational Information & Knowledge Management Services